Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GLS1 Inhibitor-7
Cat. No.:
OB0425LY-192
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
GLS1 Inhibitor-7 is qn inhibitor of glutamine synthetase 1 (GLS1) with potential antitumor activity.
Synonyms:
GLS1 Inhibitor-7; GLS1 Inhibitor7; GLS1 IN-7
Formula:
C20H17F3N4O3S2
Formula Weight:
482.5
Specification
Target:
Glutaminase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
GLS1 Inhibitor-7 can be used to study obesity-related tumor metabolism.
